// App-Quantinova.ai

3450 : Association Of Cardiac Iron By T2* With Innate Immune Markers In Transfusion-Dependent Thalassemia Patients Undergoing Combined Chelation Therapy

Researchers

Presenter

  • Patrick B Walter

Principal Investigators

  • Annie Higa

  • Vivian Ng

  • Ashutosh Lal

  • Elliott Vichinsky

  • Marcela G Weyhmiller

  • Nick R Slater

  • Patricia J. Evans

  • John B Porter

  • Nancy Sweeters

  • Jackson Price

  • Alisha Manji

  • David Killilea

Medical Centers

  • Hematology/Oncology, UCSF Benioff Childrens Hospital Oakland, Oakland, CA

  • Childrens Hospital & Research Center, Oakland, Oakland, CA

  • UCSF Benioff Childrens Hospital Oakland, Oakland, CA

  • Hematology/Oncology, UCSF Benioff Childrens Hospital Oakland, Oakland, CA

  • University of Victoria, Victoria, BC, Canada

  • Nutrition and Metabolism Center, Children's Hospital and Research Center Oakland,, Oakland, CA

  • Kings College London, London, United Kingdom

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Heart muscle disease

  • Hemochromatosis

  • Thalassemia

  • Acquired immunodeficiency syndrome

Biomarkers

  • ATPase H+ Transporting Accessory Protein 2

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 14

  • Progesterone receptor

  • Toll like receptor 4

Drug/Treatment

  • Deferoxamine

  • Deferasirox

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved